Posts Tagged ‘Alzheimer’s disease’

The FDA has granted accelerated approval for Aduhelm (aducanumab), a drug used to treat Alzheimer’s disease. Drugs approved under the accelerated approval pathway have proven to be more beneficial than what’s currently on the market for life-threatening illnesses. Considering Aduhelm is the first drug of its kind and the first Alzheimer’s treatment to be approved…